Radius Health

About:

Radius Health develops drug therapies for osteoporosis and women’s health.

Website: http://www.radiuspharm.com

Twitter/X: radius_health

Top Investors: Wellcome Trust, Nordic Bioscience, MPM Capital, Oxford Bioscience Partners, HealthCare Ventures

Description:

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The company's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging. Radius's scientific leadership includes some of the world's leading researchers in the fields of bone metabolism, endocrinology, and medicinal chemistry, and the company has a broad foundation in nuclear hormone receptors.

Total Funding Amount:

$1.03B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2003-11-01

Contact Email:

info(AT)radiuspharm.com

Founders:

John A. Katzenellenbogen, John Potts, Michael Rosenblatt, Stavros C. Manolagas

Number of Employees:

251-500

Last Funding Date:

2021-03-03

IPO Status:

Public

© 2025 bioDAO.ai